MYCN and neuroblastoma: To evaluate the potential usefulness of these chemicals for targeting the stem-like cells of neuroblastomas, we focused on SK-N-BE(2) cells due to their reported malignant potential including the amplification of MYCN expression and presence of a verapamil-sensitive side population [14].